The Nu-Med Plus, Inc. (OTCBB:NUMD) mission is to design, develop and market new patented technologies in the medical field along with building key intellectual assets. Our strategy is to focus on high growth potential markets where there is a clearly defined need recognized by the medical community that can be addressed by Nu-Med Plus technical expertise.

SEC Documents

Stock Chart, Price, Press Releases

Shareholder Letter - March 14, 2017

Shareholder Letter - January 18, 2015

Shareholder Letter - July 17, 2015

Jeff Robins -
CEO/President and Chairman of the Board
View Profile
Bill Moon -
VP of Technology and Board of Directors
View Profile
Tom Tait -
VP of Scientific Development and Board of Directors
View Profile
Dr. Craig Morrison -
VP of Research and Board of Directors
View Profile
Dr. Brett Earl -
VP of Medical Marketing and Board of Directors
View Profile
Dr. Charles Ivester Ph.D -
Medical Adviser
View Profile
Keith Merrell -
Chief Financial Officer, Secretary, and Treasurer
View Profile



Downloadable Disclosures

numd-20151231_cal.xml

numd-20151231_def.xml

numd-20151231_lab.xml

numd-20151231_pre.xml

numd-20151231.xml

numd-20151231.xsd

numd-20150930_cal.xml

numd-20150930_def.xml

numd-20150930_lab.xml

numd-20150930_pre.xml

numd-20150930.xml

numd-20150930.xsd

numd-20150630_cal.xml

numd-20150630_def.xml

numd-20150630_lab.xml

numd-20150630_pre.xml

numd-20150630.xml

numd-20150630.xsd

numd-20150331_cal.xml

numd-20150331_def.xml

numd-20150331_lab.xml

numd-20150331_pre.xml

numd-20150331.xml

numd-20150331.xsd

numd-20141231_cal.xml

numd-20141231_def.xml

numd-20141231_lab.xml

numd-20141231_pre.xml

numd-20141231.xml

numd-20141231.xsd